◆ Market Data --:--
Commodities
Loading...
📈 Yields & Rates
Loading...
💱 FX Rates
Loading...
📈 Market Pulse
Loading...
🏛 Congress Trades
Loading...
👤 Insider Trades
Loading...
Customize Items

NEUROCRINE BIOSCIENCES INC

CIK: 914475 SIC: 2836
$2.86B
Revenue
$478.60M
Net Income
98.18%
Gross Margin
21.64%
Op. Margin
$946.40M
Free Cash Flow
Financial Statements Annual (10-K)
Showing 10 of 15 annual reports available (2011 - 2025)
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
+ Total Revenue $2.86B $2.86B $2.36B $1.89B $1.49B $1.13B $1.05B $788.10M $451.20M $161.63M $15.00M
Revenue Growth % 0.0% 21.4% 24.8% 26.8% 31.3% 8.4% 32.7% 74.7% 179.2% 977.5% nan%
Cost of Revenue $52.10M $52.10M $34.00M $39.70M $23.20M $14.30M $10.10M $7.40M $4.89M $1.25M -
+ Gross Profit $2.81B $2.81B $2.32B $1.85B $1.47B $1.12B $1.04B $780.70M $446.31M $160.37M $15.00M
Gross Margin % 98.2% 98.2% 98.6% 97.9% 98.4% 98.7% 99.0% 99.1% 98.9% 99.2% 100.0%
Operating Expenses $2.24B $2.24B $1.78B $1.64B $1.24B $1.03B $882.90M $715.80M $414.40M $292.99M $162.37M
Research & Development - - - - - - - - $160.52M $121.83M $94.29M
Selling General & Admin $1.16B $1.16B $1.01B $887.60M $752.70M $583.30M $433.30M $354.10M $248.90M $169.91M $68.08M
+ Operating Income $619.10M $619.10M $570.50M $250.90M $249.00M $102.50M $163.00M $72.30M $36.80M $-131.36M $-147.37M
Operating Margin % 21.6% 21.6% 24.2% 13.3% 16.7% 9.0% 15.6% 9.2% 8.2% -81.3% -982.5%
Interest Expense - - $1.60M $4.60M $7.10M $25.80M $32.80M $32.00M $30.50M $19.52M -
Other Income/Expense $86.30M $86.30M $-84.50M $81.20M $-35.10M $-1.10M $-56.30M $-25.80M $-15.00M $-20.00K $13.00K
Income Before Tax $705.40M $705.40M $486.00M $332.10M $213.90M $101.40M $106.70M $46.50M $21.80M $-142.54M $-141.09M
Income Tax Expense $226.80M $226.80M $144.70M $82.40M $59.40M $11.80M $-300.60M $9.50M $700.00K - -
+ Net Income $478.60M $478.60M $341.30M $249.70M $154.50M $89.60M $407.30M $37.00M $21.10M $-142.54M $-141.09M
Net Margin % 16.7% 16.7% 14.5% 13.2% 10.4% 7.9% 38.9% 4.7% 4.7% -88.2% -940.6%
Basic EPS 4.82 4.81 3.40 2.56 1.61 0.95 4.38 0.40 0.23 -1.62 -1.63
Diluted EPS 4.66 4.67 3.29 2.47 1.56 0.92 4.16 0.39 0.22 -1.62 -1.63
Basic Shares Outstanding - 99.5M 100.4M 97.7M 95.8M 94.6M 93.1M 91.6M 90.2M 88.1M 86.7M
Diluted Shares Outstanding - 102.5M 103.7M 101.0M 98.9M 97.9M 97.8M 95.7M 95.4M 88.1M 86.7M
Breakdown FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Cash & Cash Equivalents $713.00M $233.00M $251.10M $262.90M $340.80M $187.10M $112.30M $141.71M $254.71M $83.27M
Short-term Investments - - - - $370.50M $613.90M $558.20M $509.20M - -
Accounts Receivable $686.80M $479.10M $439.30M $350.00M $185.50M $157.10M $126.60M $56.24M $31.13M -
Inventory $69.00M $57.40M $38.30M $35.10M $30.50M $28.00M $17.30M $10.86M $1.02M -
Other Current Assets $115.80M $112.10M $97.80M $79.10M $45.50M $30.10M $16.60M $19.76M $7.86M $3.09M
Total Current Assets $2.52B $1.72B $1.61B $1.45B $972.80M $1.02B $831.00M $737.78M $554.92M $310.44M
Property Plant & Equipment $89.80M $82.60M $70.80M $58.60M $58.60M $44.60M $41.90M $33.87M $10.81M $6.27M
Intangible Assets - $36.50M $35.50M $37.20M - - - - - -
Long-term Investments - - - $299.40M $560.70M $227.10M $299.70M $216.03M - -
Other Non-current Assets $59.50M $15.50M $49.60M $25.00M $4.40M $3.20M - - - -
Total Assets $4.63B $3.72B $3.25B $2.37B $2.07B $1.73B $1.31B $993.15M $817.59M $365.09M
Accounts Payable - - - - - - - - - $5.08M
Accrued Liabilities - - - - - - - - - $21.10M
Other Current Liabilities $69.10M $46.10M $35.90M $20.70M $20.00M $17.80M $15.20M $1.86M $113.00K -
Total Current Liabilities $743.40M $507.70M $654.80M $537.70M $245.80M $186.50M $565.30M $88.23M $54.43M $30.41M
Other Non-current Liabilities $219.70M $166.20M $106.30M $29.70M $12.30M $9.70M $17.10M $35.66M - $113.00K
Total Liabilities $1.38B $1.13B $1.02B $660.90M $698.50M $608.50M $669.10M $512.39M $445.45M $50.21M
Common Stock $100.00K $100.00K $100.00K $100.00K $100.00K $100.00K $100.00K $91.00K $89.00K $87.00K
Retained Earnings $447.70M $29.20M $-157.10M $-406.80M $-635.80M $-725.40M $-1.13B $-1.18B $-1.20B $-1.06B
Total Stockholders Equity $3.25B $2.59B $2.23B $1.71B $1.37B $1.13B $636.90M $480.80M $372.20M $314.88M
Total Liabilities & Equity $4.63B $3.72B $3.25B $2.37B $2.07B $1.73B $1.31B $993.15M $817.59M $365.09M
Breakdown TTM
(Dec 31, 2025)
FY 2025
(Dec 31, 2025)
FY 2024
(Dec 31, 2024)
FY 2023
(Dec 31, 2023)
FY 2022
(Dec 31, 2022)
FY 2021
(Dec 31, 2021)
FY 2020
(Dec 31, 2020)
FY 2019
(Dec 31, 2019)
FY 2018
(Dec 31, 2018)
FY 2017
(Dec 31, 2017)
FY 2016
(Dec 31, 2016)
Net Income $478.60M $478.60M $341.30M $249.70M $154.50M $89.60M $407.30M $37.00M $21.10M $-142.54M $-141.09M
Depreciation & Amortization - - - - - - - - $4.02M $2.40M $1.45M
Stock-based Compensation $376.30M $217.90M $195.50M $194.30M $173.10M $134.20M $100.00M $75.30M $58.10M $42.52M $28.46M
Deferred Income Tax - $164.20M $-123.00M $-60.70M - - - - - - -
Change in Receivables $364.00M $210.50M $39.80M $89.30M $162.20M $28.40M $30.50M $69.20M $25.10M $31.13M -
Change in Inventory $16.60M $15.30M $19.10M $-5.40M $2.60M $2.50M $10.70M $6.40M $3.50M $1.02M -
Operating Cash Flow $1.01B $782.70M $595.40M $389.90M $339.40M $256.50M $228.50M $147.00M $101.40M $-94.33M $-106.18M
Capital Expenditure $67.90M $34.00M $38.20M $28.30M $16.50M $23.40M $10.90M $14.70M $24.80M $6.94M $4.11M
Acquisitions - - - - $42.70M - - - - - -
Purchases of Investments - - - - - - - $797.17M $545.96M $583.41M $298.78M
Investing Cash Flow $-265.00M $-264.40M $-126.80M $-467.10M $-177.10M $-130.20M $4.10M $-211.10M $-242.90M $-251.25M $112.95M
Stock Issued $208.00M $129.40M $122.10M $65.30M $44.70M $27.50M $29.10M $32.40M $29.50M $13.87M $2.39M
Stock Repurchased $485.40M $167.70M $300.00M - - - - - - - -
Financing Cash Flow $-277.40M $-38.30M $-486.70M $65.30M $-234.30M $27.40M $-157.80M $32.40M $29.50M $516.65M $2.39M
Net Change in Cash $472.10M $480.00M $-18.10M $-11.60M $-73.30M $153.70M $74.80M $-31.70M $-112.00M $171.06M $9.16M
SEC Filing Format - Data shown as it appears in the Q3 2025 (10-Q) filing Period ended: Sep 30, 2025
Condensed Consolidated Statements of Operations
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Total Revenue $794.90M - $2.06B -
Cost of Revenue $14.00M - $34.50M -
Operating Expenses $555.90M - $1.65B -
Selling General & Admin $291.60M - $854.40M -
Operating Income $239.00M - $408.20M -
Interest Expense - - - -
Other Income/Expense $52.80M - $57.80M -
Income Before Tax $291.80M - $466.00M -
Income Tax Expense $82.30M - $141.10M -
Net Income $209.50M - $324.90M -
Basic EPS 2.11 - 3.27 -
Diluted EPS 2.04 - 3.19 -
Basic Shares Outstanding $99.40M - $99.30M -
Diluted Shares Outstanding $102.50M - $102.00M -
Condensed Consolidated Balance Sheets
Description Sep 30, 2025 Dec 31, 2024
Cash & Cash Equivalents $340.20M $233.00M
Accounts Receivable $728.00M $479.10M
Inventory $69.30M $57.40M
Other Current Assets $68.20M $63.60M
Total Current Assets $2.16B $1.72B
Property Plant & Equipment $97.30M $82.60M
Intangible Assets $35.70M $36.50M
Other Non-current Assets $20.30M $15.50M
Total Assets $4.27B $3.72B
Other Current Liabilities $53.70M $46.10M
Total Current Liabilities $638.00M $507.70M
Other Non-current Liabilities $195.70M $166.20M
Total Liabilities $1.26B $1.13B
Common Stock $100.00K $100.00K
Retained Earnings $294.00M $29.20M
Total Stockholders Equity $3.00B $2.59B
Total Liabilities & Equity $4.27B $3.72B
Condensed Consolidated Statements of Cash Flows
Description Sep 30, 2025 Sep 30, 2025
Current Prior Year Current YTD Prior Year YTD
Net Income $209.50M - $324.90M -
Stock-based Compensation - - $159.30M -
Change in Receivables - - $248.90M -
Change in Inventory - - $11.90M -
Operating Cash Flow - - $394.30M -
Capital Expenditure - - $36.40M -
Investing Cash Flow - - $-211.50M -
Stock Issued - - $92.10M -
Stock Repurchased - - $167.70M -
Financing Cash Flow - - $-75.60M -
Net Change in Cash - - $107.20M -

All values are in USD (United States Dollars). Data is sourced from SEC EDGAR 10-K filings.

Annual data represents full fiscal year results. FY = Fiscal Year ending.

NEWS
Loading article...
NEWS
Loading news...
TRENDING
Loading...